Structure-function relation of phospholamban: modulation of channel activity as a potential regulator of SERCA activity
- PMID: 23308118
- PMCID: PMC3537670
- DOI: 10.1371/journal.pone.0052744
Structure-function relation of phospholamban: modulation of channel activity as a potential regulator of SERCA activity
Abstract
Phospholamban (PLN) is a small integral membrane protein, which binds and inhibits in a yet unknown fashion the Ca(2+)-ATPase (SERCA) in the sarcoplasmic reticulum. When reconstituted in planar lipid bilayers PLN exhibits ion channel activity with a low unitary conductance. From the effect of non-electrolyte polymers on this unitary conductance we estimate a narrow pore with a diameter of ca. 2.2 Å for this channel. This value is similar to that reported for the central pore in the structure of the PLN pentamer. Hence the PLN pentamer, which is in equilibrium with the monomer, is the most likely channel forming structure. Reconstituted PLN mutants, which either stabilize (K27A and R9C) or destabilize (I47A) the PLN pentamer and also phosphorylated PLN still generate the same unitary conductance of the wt/non-phosphorylated PLN. However the open probability of the phosphorylated PLN and of the R9C mutant is significantly lower than that of the respective wt/non-phosphorylated control. In the context of data on PLN/SERCA interaction and on Ca(2+) accumulation in the sarcoplasmic reticulum the present results are consistent with the view that PLN channel activity could participate in the balancing of charge during Ca(2+) uptake. A reduced total conductance of the K(+) transporting PLN by phosphorylation or by the R9C mutation may stimulate Ca(2+) uptake in the same way as an inhibition of K(+) channels in the SR membrane. The R9C-PLN mutation, a putative cause of dilated cardiomyopathy, might hence affect SERCA activity also via its inherent low open probability.
Conflict of interest statement
Figures





Similar articles
-
Activating and deactivating roles of lipid bilayers on the Ca(2+)-ATPase/phospholamban complex.Biochemistry. 2011 Nov 29;50(47):10367-74. doi: 10.1021/bi200759y. Epub 2011 Nov 8. Biochemistry. 2011. PMID: 21992175 Free PMC article.
-
Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.Circulation. 2009 Jan 27;119(3):436-44. doi: 10.1161/CIRCULATIONAHA.108.783506. Epub 2009 Jan 12. Circulation. 2009. PMID: 19139388
-
Phospholamban phosphorylation increases the passive calcium leak from cardiac sarcoplasmic reticulum.Pflugers Arch. 2012 Sep;464(3):295-305. doi: 10.1007/s00424-012-1124-9. Epub 2012 Jul 7. Pflugers Arch. 2012. PMID: 22772476
-
Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy.Biochem Cell Biol. 2015 Feb;93(1):1-7. doi: 10.1139/bcb-2014-0080. Epub 2014 Dec 1. Biochem Cell Biol. 2015. PMID: 25563649 Review.
-
The SarcoEndoplasmic Reticulum Calcium ATPase.Subcell Biochem. 2018;87:229-258. doi: 10.1007/978-981-10-7757-9_8. Subcell Biochem. 2018. PMID: 29464562 Review.
Cited by
-
Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing.Sci Rep. 2015 Nov 17;5:16609. doi: 10.1038/srep16609. Sci Rep. 2015. PMID: 26573135 Free PMC article.
-
Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.J Biol Chem. 2015 Mar 13;290(11):7130-40. doi: 10.1074/jbc.M114.630319. Epub 2015 Jan 15. J Biol Chem. 2015. PMID: 25593317 Free PMC article.
-
Transfer Learning in Cancer Genetics, Mutation Detection, Gene Expression Analysis, and Syndrome Recognition.Cancers (Basel). 2024 Jun 4;16(11):2138. doi: 10.3390/cancers16112138. Cancers (Basel). 2024. PMID: 38893257 Free PMC article. Review.
-
Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies.Chem Rev. 2018 Apr 11;118(7):3559-3607. doi: 10.1021/acs.chemrev.7b00570. Epub 2018 Feb 28. Chem Rev. 2018. PMID: 29488756 Free PMC article. Review.
-
Structural dynamics and topology of phosphorylated phospholamban homopentamer reveal its role in the regulation of calcium transport.Structure. 2013 Dec 3;21(12):2119-30. doi: 10.1016/j.str.2013.09.008. Epub 2013 Oct 24. Structure. 2013. PMID: 24207128 Free PMC article.
References
-
- Schmidt AG, Edes I, Kranias EG (2001) Phospholamban: a promising therapeutic target in heart failure? Cardiovasc Drugs Ther 15: 387–396. - PubMed
-
- Tadini-Buoninsegni F, Bartolommei G, Moncelli MR, Guidelli R, Inesi G (2006) Pre-steady State Electrogenic Events of Ca2+/H+ Exchange and Transport by the Ca2+-ATPase. J Biol Chem 281: 37720–37727. - PubMed
-
- Cornea RL, Jones LR, Autry JM, Thomas DD (1997) Mutation and Phosphorylation Change the Oligomeric Structure of Phospholamban in Lipid Bilayers. Biochemistry 36: 2960–2967. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous